Mohammedi K - Search Results

1

Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: protocol for a nationwide observational comparative study in routine care.

Danchin N, Lemesle G, Mazighi M, Mohammedi K, Schiele F, Sibon I, Caron A, Emery C, Nevoret C, Vigié L, Massien C, Detournay B, Fauchier L. Danchin N, et al. Among authors: mohammedi k. BMJ Open. 2025 Jan 9;15(1):e087790. doi: 10.1136/bmjopen-2024-087790. BMJ Open. 2025. PMID: 39788759 Free article.

2

Rarity of congenital adrenal hyperplasia in children born very preterm:Possible mechanism and implication for newborn screening.

Ladjouze A, Ouarezki Y, Djermane A, Kherra S, Bensalah M, Mohammedi K, Douiri D, Boutaghane N, Bouzerar Z, Van Vliet G. Ladjouze A, et al. Among authors: mohammedi k. Horm Res Paediatr. 2025 Jan 6:1-14. doi: 10.1159/000543430. Online ahead of print. Horm Res Paediatr. 2025. PMID: 39761670

3

Genetic predisposition to nephropathy and associated cardiovascular disease in people with type 1 diabetes: role of the angiotensinI-converting enzyme (ACE), and beyond; a narrative review.

Mohammedi K, Marre M, Alhenc-Gelas F. Mohammedi K, et al. Cardiovasc Diabetol. 2024 Dec 21;23(1):453. doi: 10.1186/s12933-024-02544-0. Cardiovasc Diabetol. 2024. PMID: 39709470 Free PMC article. Review.

4

Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications.

Rigalleau V, Pucheux Y, Couffinhal T, Tessier FJ, Howsam M, Rubin S, Helmer C, Alkhami F, Larroumet A, Blanco L, Barbet-Massin MA, Ferriere A, Mohammedi K, Foussard N. Rigalleau V, et al. Among authors: mohammedi k. Diabetes Metab. 2024 Dec 6;51(1):101600. doi: 10.1016/j.diabet.2024.101600. Online ahead of print. Diabetes Metab. 2024. PMID: 39647777 Review.

5

Determination of glycation biomarkers in human fingernails by isotope-dilution liquid chromatography tandem mass spectrometry (LC-MS/MS).

Tessier FJ, Jaramillo Ortiz S, Nguyen DH, Mohammedi K, Delcourt C, Helmer C, Le Goff M, Boulanger E, Rigalleau V, Howsam M. Tessier FJ, et al. Among authors: mohammedi k. Clin Chim Acta. 2025 Jan 30;566:120036. doi: 10.1016/j.cca.2024.120036. Epub 2024 Nov 15. Clin Chim Acta. 2025. PMID: 39551231

6

Relationships between ankle blood pressure indices and major adverse cardiovascular events in people with and without type 2 diabetes.

Mohammedi K, Pigeyre M, Bosch J, Yusuf S, Gerstein HC. Mohammedi K, et al. Cardiovasc Diabetol. 2024 Sep 3;23(1):325. doi: 10.1186/s12933-024-02383-z. Cardiovasc Diabetol. 2024. PMID: 39227845 Free PMC article.

7

Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.

Mahé G, Aboyans V, Cosson E, Mohammedi K, Sarlon-Bartoli G, Lanéelle D, Mirault T, Darmon P. Mahé G, et al. Among authors: mohammedi k. Cardiovasc Diabetol. 2024 Jun 26;23(1):220. doi: 10.1186/s12933-024-02325-9. Cardiovasc Diabetol. 2024. PMID: 38926722 Free PMC article. Review.

8

Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" study.

Mohammedi K, Fauchier L, Quignot N, Khachatryan A, Banon T, Kapnang R, Kikuchi K, Ren H, Massien C, Vigié L, Larsen S, Sibon I. Mohammedi K, et al. Cardiovasc Diabetol. 2024 May 29;23(1):183. doi: 10.1186/s12933-024-02257-4. Cardiovasc Diabetol. 2024. PMID: 38812009 Free PMC article.

9

A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes.

Bourron O, Mohammedi K, De Keizer J, Schneider F, Hadjadj S, Saulnier PJ. Bourron O, et al. Among authors: mohammedi k. Diabetes Obes Metab. 2024 Aug;26(8):3290-3298. doi: 10.1111/dom.15656. Epub 2024 May 15. Diabetes Obes Metab. 2024. PMID: 38747240

10

Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial.

Mohammedi K, Hess S, McQueen M, Pigeyre M, Lee SF, Pare G, Gerstein HC. Mohammedi K, et al. Diabetes Obes Metab. 2024 Aug;26(8):3272-3280. doi: 10.1111/dom.15654. Epub 2024 May 15. Diabetes Obes Metab. 2024. PMID: 38747213 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters